About Iom Bioworks
Iom Bioworks is a company based in Bengaluru (India) founded in 2022 by Hiroaki Kitano, Samik Ghosh, and Bipin Pradeep Kumar. Iom Bioworks has raised $521.33 thousand across 2 funding rounds from investors including IP Ventures. The company has 1 employees as of April 05, 2024. Iom Bioworks operates in a competitive market with competitors including Genefitletics, MicrobioTx and Microbiome Research, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 05 Apr, 2024
- Founders Hiroaki Kitano, Samik Ghosh, Bipin Pradeep Kumar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iom Bioworks Private Limited
- Date of Incorporation 25 Jul, 2022
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$51.07 K (USD)0as on Mar 31, 2023
-
Net Profit
-$22.26 K (USD)0as on Mar 31, 2023
-
EBITDA
-$23.53 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$521.33 K (USD)
in 2 rounds
-
Latest Funding Round
$53.54 K (USD), Angel Round
May 02, 2026
- Investors
-
Employee Count
1
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Iom Bioworks
Iom Bioworks has successfully raised a total of $521.33K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $53.54 thousand completed in May 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Iom Bioworks
Iom Bioworks has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IP Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage tech startups across sectors.
|
Locked | Locked | Locked |
Investor details for Iom Bioworks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Iom Bioworks
Investment portfolio details for Iom Bioworks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Iom Bioworks
Detailed financials for Iom Bioworks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iom Bioworks Comparisons
Peer comparison for Iom Bioworks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Iom Bioworks
Iom Bioworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genefitletics, MicrobioTx and Microbiome Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Early detection tests for metabolic diseases and cancer are offered.
|
|
| Locked | Locked | Locked |
Gut-microbiome solutions for personalized wellness are provided.
|
|
| Locked | Locked | Locked |
Provides gut health tests, personalized recommendations, and consultations for individuals.
|
Detailed competitors of Iom Bioworks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iom Bioworks
Complete news archive for Iom Bioworks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iom Bioworks
Iom Bioworks was founded in 2022 and raised its 1st funding round 3 years after it was founded.
Iom Bioworks is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Bipin Pradeep Kumar is the current CEO of Iom Bioworks. They have also founded this company.
Iom Bioworks is a funded company, having raised a total of $521.33K across 2 funding rounds to date.
As of Apr 05, 2024, the latest employee count at Iom Bioworks is 1.
Annual revenue of Iom Bioworks is $51.07K as on Mar 31, 2023.
Iom Bioworks was founded in 2022 in Bengaluru, India, within the healthtech sector focused on personalized nutrition. Home-based test kits are provided for gut microbiome analysis, followed by consultations that generate tailored meal plans. Operations center on bacterial composition assessments to inform dietary recommendations, serving individuals seeking microbiome-informed health solutions.
Iom Bioworks's top competitors include Genefitletics, MicrobioTx and Microbiome Research.
Iom Bioworks has 1 investor. Key investors include IP Ventures.